preferred indications of clofibrate therapy are hypertriglyceridemias in type iib , type iii , type iv , and type v hyperlipoproteinemia ( in combination with other pharmaceuticals ) and refractory hypercholesterolemias in type iia and type iib hyperlipoproteinemia .
C0020557
hypertriglyceridemias
C0020481
type v hyperlipoproteinemia